Vermillion Wealth Management, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1737012
ROSEMOUNT, MN
Position in VRTX
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$8,037
New position
Shares Held
18
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vermillion Wealth Management, Inc. holds $68,753 across 7 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
500 | $27,470 | |
| 2 | CAI |
Caris Life Sciences, Inc.
|
1,000 | $17,820 | |
| 3 | SMMT |
Summit Therapeutics Inc.
|
1,000 | $14,570 | |
| 4 | AVXL |
Anavex Life Sciences Corp.
|
2,000 | $5,180 | |
| 5 | CELC |
Celcuity Inc.
|
20 | $2,092 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
1,500 | $1,108 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
140 | $513 |
All Filings in VRTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,037 | 18 | Shares | Sole | 2026-04-17 | |
| No filing history on record for this holder in this stock. | ||||||